Global Neonatal Infants Enteral Feeding Devices Market Report 2024

The neonatal infants enteral feeding devices market size has grown steadily in recent years. It will grow from $2.1 billion in 2023 to $2.17 billion in 2024 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increasing premature birth rates, rising incidences of neonatal disorders, growing demand for specialized neonatal care, and expanding healthcare infrastructure.

The neonatal infants enteral feeding devices market size is expected to see steady growth in the next few years. It will grow to $2.5 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. The projected growth in the forecast period can be credited to several factors, including the increasing adoption of enteral nutrition within neonatal intensive care units, escalating investments in healthcare infrastructure across emerging markets, growing recognition of the benefits associated with enteral feeding for neonates, broader utilization of enteral feeding devices in homecare environments, and ongoing advancements in enteral feeding technology aimed at enhancing patient outcomes. Notable trends anticipated in the forecast period encompass technological innovations, the trend toward miniaturization of enteral feeding devices, the integration of smart technology to enable remote monitoring, the development of specialized enteral formulas tailored specifically for neonates, a heightened emphasis on infection prevention and control protocols, and the emergence of personalized nutrition solutions designed to provide individualized care.

The increasing incidence of preterm birth is anticipated to drive the growth of the neonatal infant enteral feeding devices market in the future. Preterm birth, defined as birth before completing 37 weeks of gestation, poses various health challenges due to incomplete development. Factors contributing to the prevalence of preterm birth include advanced maternal age, lifestyle choices, medical interventions such as assisted reproductive technologies, maternal health conditions, and environmental influences. Neonatal infant enteral feeding devices play a crucial role in delivering essential nutrition directly into the stomach or intestines of premature infants who cannot orally feed, thereby supporting their growth and development. For instance, data from the Office for National Statistics in January 2023 revealed a slight increase in the percentage of preterm live births from 7.4% in 2020 to 7.5% in 2021, indicating a growing need for neonatal infant enteral feeding devices.

The rising number of neonatal admissions is expected to fuel the expansion of the neonatal infant enteral feeding devices market. Neonatal admissions involve hospitalization or admission of newborn infants, typically within the first 28 days of life, for medical care and monitoring. Neonatal infant enteral feeding devices are instrumental in providing specialized medical interventions and monitoring for premature or critically ill infants, addressing their immediate health requirements and enhancing their chances of survival and healthy development. For instance, according to the American Academy of Pediatrics in October 2023, the percentage of infants classified as late preterm (LPT) and low birth weight (LBW) receiving exclusive care in the nursery increased from 83.9% to 88.8% due to special circumstances, highlighting the growing demand for neonatal infant enteral feeding devices.

Major companies in the neonatal infant enteral feeding devices market are focusing on developing products with advanced technologies such as real-time assessment technology to monitor feeding and ensure optimal nutrition, thereby mitigating the risk of complications. Real-time assessment technology enhances feeding precision, safety, early issue detection, data-driven decision-making, parental involvement, and overall efficiency in neonatal care. For example, in August 2023, Cardinal Health launched its next-generation NTrainer System 2.0, a medical device aimed at helping premature and newborn infants develop oral coordination skills necessary for transitioning to independent feeding faster. This FDA Class II biofeedback device utilizes real-time assessment technology to provide clinicians with objective data to track an infant's progress in developing pre-feeding skills.

Major companies operating in the neonatal infants enteral feeding devices market are Cardinal Health Inc., Abbott Inc., 3M, Medtronic Plc, Kimberly-Clark Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Fresenius Kabi AG, Terumo Corporation, Coloplast Corp., B. Braun Melsungen AG, Moog Inc., Cook Medical Inc., Teleflex Incorporated, ConvaTec Inc., Halyard Health Inc., Hollister Incorporated, CONMED Corporation, Avanos Medical Inc., Amsino International Inc., Nutricia, Vygon SA, Wellspect Healthcare, Applied Medical Technology Inc., Qosina Corporation.

North America was the largest region in the neonatal infants enteral feeding devices market in 2023. The regions covered in the neonatal infants enteral feeding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neonatal infants enteral feeding devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Neonatal infants' enteral feeding devices are specialized medical tools engineered specifically for delivering enteral nutrition to premature or critically ill newborns who are unable to feed orally. These devices play a crucial role in administering vital nutrients, fluids, and medications directly into the gastrointestinal tract of neonates, thereby facilitating their growth, development, and recovery within the neonatal intensive care unit (NICU) or special care nursery.

The primary products in this category include gastrostomy tubes, jejunostomy tubes, duodenostomy tubes, nasal feeding tubes, and oropharyngeal feeding tubes. Gastrostomy tubes, for instance, are medical instruments inserted through the abdomen into the stomach, providing essential nutrition and medication to individuals who cannot consume food orally due to medical conditions. These tubes are manufactured from various materials such as silicone, polyurethane, and polyvinyl chloride, available in different sizes tailored for both preterm and full-term infants. They find utility across various settings including clinics, hospitals, ambulatory care facilities, home use, and others.

The neonatal infants enteral feeding devices market research report is one of a series of new reports that provides neonatal infants enteral feeding devices market statistics, including neonatal infants enteral feeding devices industry global market size, regional shares, competitors with a neonatal infants enteral feeding devices market share, detailed neonatal infants enteral feeding devices market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal infants enteral feeding devices industry. This neonatal infants enteral feeding devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neonatal infants enteral feeding devices market consists of sales of nasogastric tubes, orogastric tubes, specialized feeding pumps, and accessories for delivering nutrition to newborns who cannot feed orally. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.